Abrahamson D R, Caulfield J P
J Exp Med. 1982 Jul 1;156(1):128-45. doi: 10.1084/jem.156.1.128.
Antibodies against laminin, which is a defined glycoprotein of basement membranes, were produced in sheep and affinity purified by immunoadsorption on laminin-Sepharose (S alpha L). When injected intravenously into rats, S alpha L rapidly bound in a linear pattern to the glomerular basement membrane (GBM) in the peripheral and mesangial regions of all glomeruli, and, when greater than 0.5 mg S alpha L was injected, to some tubular BM as well. 1-2 h after the injection of conjugates of horseradish peroxidase (HRP) and S alpha L, HRP reaction product was present throughout the full thickness of the GBM and mesangial matrix. [125I]S alpha L binding to the kidney in vivo increased linearly over the dose range of 40-950 micrograms of IgG and accounted for approximately 2% of the injected dose/g kidney. When 4 mg of [125I]S alpha L was injected, 1.5% or 62 micrograms/g kidney was bound. Proteinuria did not develop within 7 wk of injection in rats that received 0.5-1.6 mg of S alpha L. In contrast, all animals that received injections of 4 mg of S alpha L gradually became proteinuric within 3-6 wk. Thickening, reduplication, and flocculent subendothelial deposits were observed in the GBM of these animals. In addition, mononuclear cells adhered to the GBM and infiltrated beneath the endothelium. However, the deposition of rat C3 was infrequently observed, and rat IgG was not seen in the glomeruli of any rat that received S alpha L. 10 wk after injection, much greater amounts of S alpha L appeared within the mesangium than the peripheral GBM. These results demonstrate that the interaction of S alpha L with the GBM, possibly in concert with infiltrating mononuclear cells, gradually altered the structure and permeability characteristics of the glomerulus independent of a host anti-S alpha L humoral response.
抗层粘连蛋白的抗体在绵羊体内产生,层粘连蛋白是基底膜中的一种特定糖蛋白,通过在层粘连蛋白-琼脂糖(SαL)上进行免疫吸附进行亲和纯化。当静脉注射到大鼠体内时,SαL以线性模式迅速结合到所有肾小球外周和系膜区域的肾小球基底膜(GBM)上,并且当注射量大于0.5mg SαL时,也会结合到一些肾小管基底膜上。注射辣根过氧化物酶(HRP)与SαL的结合物1 - 2小时后,HRP反应产物出现在GBM和系膜基质的整个厚度中。体内[125I]SαL与肾脏的结合在40 - 950微克IgG的剂量范围内呈线性增加,约占每克肾脏注射剂量的2%。当注射4mg [125I]SαL时,每克肾脏结合1.5%或62微克。接受0.5 - 1.6mg SαL注射的大鼠在注射后7周内未出现蛋白尿。相反,所有接受4mg SαL注射的动物在3 - 6周内逐渐出现蛋白尿。在这些动物的GBM中观察到增厚、重复和絮状内皮下沉积物。此外,单核细胞粘附在GBM上并在内皮细胞下方浸润。然而,很少观察到大鼠C3的沉积,并且在任何接受SαL注射的大鼠肾小球中均未见到大鼠IgG。注射10周后,系膜中出现的SαL量比外周GBM中多得多。这些结果表明,SαL与GBM的相互作用,可能与浸润的单核细胞协同作用,逐渐改变了肾小球的结构和通透性特征,而与宿主抗SαL体液反应无关。